Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VM-1500 vs Efavirenz in Treatment-Naïve HIV-1
NCT02489461Phase 3Completed
- Sponsor
- Viriom Inc
- Start
- Aug 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of depulfavirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Viriom Inc. Started Aug 2014; status: completed.
02
Drugs
depulfavirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02489461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489461.